As shown here, urine levels of 5’-AMP and 5’-GMP did not differ significantly between patients with AKI versus patients without AKI suggesting that reduced CD73 expression may be the underlying cause of diminished urine levels of renoprotective purines in COVID-19 AKI patients. This evidence concerns the gene NT5E and acute kidney injury.